Collaboration Accelerates Innovation in Ultrafast Electron Microscopy, Enabling Cutting-Edge Research and Industrial Applications
Göttingen, 2.12.2024
JEOL-IDES, a leading company in the development of scientific instruments, has licensed an innovative electron beam technology from the Max Planck Institute for Multidisciplinary Sciences (MPI-NAT) and the Georg-August-University Göttingen (Germany). Developed in the research team led by Professor Claus Ropers, the technology drastically enhances ultrafast transmission electron microscopy (UTEM), providing unprecedented precision for advanced imaging applications.
read more
UMG and SubRed Therapeutics aim to jointly develop a therapy for treatment of a rare, devastating childhood disease
Göttingen, 14.6.2023
In the Department of Pediatrics and Adolescent Medicine at UMG, scientists led by Dr. Lars Schlotawa have developed a therapeutic approach that may lead to the first effective treatment of the rare neurometabolic disease MSD (multiple sulfatase deficiency). Through the mediation of MBM ScienceBridge, the Australian pharmaceutical company SubRed Therapeutics, a subsidiary of Tarnagulla Ventures, was chosen as a partner for further development of the therapeutic approach. The common goal of UMG and SubRed is to jointly develop a therapy and achieve its approval as the first drug for the treatment of MSD.
read more
mRNA vaccine production from small to large scale
Göttingen, 30.3.2023
MBM ScienceBridge today announced the successful negotiation and execution of an exclusive worldwide commercialization agreement between Technical University (TU) Clausthal and Dillico SAS.
read more
New Method of Genotyping in Plant Breeding
Göttingen, 20.09.2022
MBM ScienceBridge GmbH has successfully negotiated a contract for an exclusive license between the Georg-August University of Göttingen and the Lower Saxony plant breeding company KWS SAAT SE & Co. KGaA.
read more
